New York, April 21, 2015 -- Moody's Investors Service has assigned an overall covenant quality score of 3.53 to Horizon Pharma Financing Inc.'s$300m _% Senior Notes due 2023. Subscribers can read the full report at:

Vollständigen Artikel bei Moodys lesen